GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acepodia Inc (ROCO:6976) » Definitions » Other Gross PPE

Acepodia (ROCO:6976) Other Gross PPE : NT$579.10 Mil (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Acepodia Other Gross PPE?

Acepodia's Other Gross PPE for the quarter that ended in Dec. 2024 was NT$579.10 Mil.

Acepodia's quarterly Other Gross PPE increased from Dec. 2023 (NT$443.33 Mil) to Jun. 2024 (NT$567.81 Mil) and increased from Jun. 2024 (NT$567.81 Mil) to Dec. 2024 (NT$579.10 Mil).

Acepodia's annual Other Gross PPE increased from Dec. 2022 (NT$83.50 Mil) to Dec. 2023 (NT$443.33 Mil) and increased from Dec. 2023 (NT$443.33 Mil) to Dec. 2024 (NT$579.10 Mil).


Acepodia Other Gross PPE Historical Data

The historical data trend for Acepodia's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acepodia Other Gross PPE Chart

Acepodia Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Other Gross PPE
21.27 88.56 83.50 443.33 579.10

Acepodia Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Other Gross PPE Get a 7-Day Free Trial 83.50 341.46 443.33 567.81 579.10

Acepodia Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


Acepodia Business Description

Traded in Other Exchanges
N/A
Address
17th floor-12, Number 99, Section 1, Xintai 5th Road, Xizhi District, New Taipei, TWN, 22175
Acepodia Inc is a clinical stage biotechnology company engaged to develop innovative highly effective first-in-class cell therapies by using Antibody-Cell Conjugation platform technology for cancer that are broadly accessible for patients.

Acepodia Headlines

No Headlines